First Time Loading...
A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 35.4 GBX 0.71% Market Closed
Updated: May 18, 2024

Alliance Pharma PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alliance Pharma PLC
Income from Continuing Operations Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
A
Alliance Pharma PLC
LSE:APH
Income from Continuing Operations
-£7.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Income from Continuing Operations
£4.8B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Income from Continuing Operations
$6.3B
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
12%
Indivior PLC
LSE:INDV
Income from Continuing Operations
$5m
CAGR 3-Years
-63%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Income from Continuing Operations
$192m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Income from Continuing Operations
-£27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alliance Pharma PLC's Income from Continuing Operations?
Income from Continuing Operations
-7.1m GBP

Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Income from Continuing Operations amounts to -7.1m GBP.